TalkMed Group, a Singapore oncology provider, accepts a $447 million privatization offer from TW Troy.

TalkMed Group, a Singapore healthcare provider specializing in oncology services, received a privatization offer from TW Troy, valued at $447 million. The offer provides a significant premium over TalkMed's stock price and net asset value, aiming to enhance patient care and medical tourism in Singapore. The deal, which includes an investment from Temasek-backed partners, is expected to bring more services and expertise under one network, potentially improving access to advanced treatments.

3 months ago
4 Articles

Further Reading